Future HIV Therapy
Drug Resistance Differences Among HIV Types and Subtypes: A Growing Problem CME

Disclosures

Release Date: November 21, 2008; Valid for credit through November 21, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. Drug Resistance Differences Among HIV Types and Subtypes: A Growing Problem
    Marcelo A. Soares, PhD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the most common subtype of HIV-1 worldwide
  2. Describe the role of genetic variability in the baseline and acquired resistance of HIV to antiretroviral therapy
  3. List limitations of algorithms used to interpret HIV genotypic resistance
  4. Describe the impact of HIV-1 subtype and ethnicity on the clinical response to antiretroviral therapy
Authors and Disclosures

Marcelo A. Soares, PhD
Disclosure: Marcelo A. Soares, PhD, has disclosed no relevant financial relationships


Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.


Elisa Manzotti
Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

Medscape    MedscapeCME    eMedicine    Drugs    MEDLINE    All
All material on this website is protected by copyright, Copyright © 1994-2009 by Medscape. This website also contains material copyrighted by 3rd parties.